Vaccines
8 April 2013
Dainippon Sumitomo Pharma and Chugai Pharmaceutical Terminate Joint Development of Cancer Vaccine27 March 2013
SUCCESSFUL VACCINE DEVELOPMENTS AT THEMIS BIOSCIENCE25 February 2013
Dynavax Receives FDA Complete Response Letter on HEPLISAV(TM) Biologic License Application25 February 2013
Circassia’s ToleroMune Cat Allergy Treatment Maintains Symptom Improvement Two Years After Start of Short-Course Therapy24 February 2013
European Medicines Agency Recommends Approval of Hexyon/Hexacima 6-in-1 Pediatric Vaccine21 February 2013
Data Published in PLOS ONE Show Mymetics’ HIV-1 Innovative Vaccine is Safe and Elicits Strong Immunogenicity14 February 2013
Argos Therapeutics Announces Updated Phase 2 Data for AGS-003 Personalized Immunotherapy for Metastatic Renal Cell Carcinoma12 February 2013
EpiVax-Novozymes Tregitope-Albumin Fusion Moves ‘Paradigm-Shifting’ Treatment for Diabetes Closer to Clinical TrialsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports